Tivic Health Systems (Nasdaq:TIVC) announced today that it completed enrollment in a study for its vagus nerve stimulation (VNS) device.
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...
PopCrush on MSN7h
FDA Proposes Ban of NyQuil, Sudafed and Benadryl — Here's WhyFound in almost every single over-the-counter cold, sinus and allergy medication, oral phenylephrine, is pretty close to ...
Now that cold and flu season is upon us, our wellness editors are using these hacks to avoid sickness and stay healthy.
CINCINNATI (WKRC) - The Food and Drug Administration (FDA) is considering removing oral phenylephrine, a common ingredient in ...
A common cold medicine has been deemed ineffective and will no longer ... not effective as a nasal decongestant,” said Dr.
Friedman, a board-certified neuro-ophthalmologist and headache medicine specialist. With this in mind ... move to build out Tonix's commercial infrastructure ahead of the FDA submission of its New ...
When you have a cold and go into the drug store, your over-the-counter treatment options are endless. Dr. Justin Skrzynski of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback